WallStreetZenWallStreetZen

NASDAQ: NNNN
Anbio Biotechnology Revenue

OverviewEarningsRevenue
DividendOwnership
Anbio Biotechnology revenue was N/A for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2024) ending on Jun 30, 2024 was N/A, down N/A from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, NNNN annual revenue was $6.7M, with -71.5% growth year-over-year.

NNNN revenue history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

Be the first to know when NNNN announces revenue.

NNNN Revenue History By Year

NNNN Yearly RevenueNNNN RevenueNNNN ChangeNNNN Revenue Growth
2023-12-31$6.71M-$16.83M-71.49%
2022-12-31$23.54MN/AN/A

1 of 1

Anbio Biotechnology Revenue FAQ

What was Anbio Biotechnology's annual revenue growth in the past year?

As of Q2 2025, Anbio Biotechnology's revenue has grown null year over year. Anbio Biotechnology's revenue in the past year totaled N/A.

How much does Anbio Biotechnology make in a year?

Anbio Biotechnology's revenue by year for the past one years is:
  • Anbio Biotechnology's revenue for the twelve months ending Dec 31, 2023 was $6.71 million, a 71.49% decrease year over year.

What was Anbio Biotechnology's revenue in 2023?

Anbio Biotechnology's annual revenue for the twelve months ending Dec 31, 2023 was $6.71 million, a 71.49% decrease year over year.

How much does Anbio Biotechnology make in a day?

Based on Anbio Biotechnology annual revenue for the past one years, NNNN makes an average of $18,389.01 per day.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.